Send to

Choose Destination
Anatol J Cardiol. 2020 Jan;23(1):2-9. doi: 10.14744/AnatolJCardiol.2019.39293.

The implications and requirements of transcatheter aortic valve replacement in low-risk patients.

Author information

Department of Cardiology, Heart and Vascular Institute, Cleveland Clinic; Abu Dhabi-United Arab Emirates.


Transcatheter aortic valve replacement (TAVR) is a transformative technology that has changed the management of patients with severe, symptomatic aortic stenosis. The use of TAVR in intermediate- to high-risk patients has been validated in several rigorously performed, randomized clinical trials. Recent studies using newer generation devices have demonstrated the noninferiority of TAVR as compared with surgical aortic valve replacement in low-risk patients, supporting the increased utilization and expansion of TAVR. The use of TAVR in low-risk patients has important implications and requires a multifaceted approach that includes a highly functional multidisciplinary heart team for careful patient selection; a need to understand and help mitigate certain key complications, such as stroke, paravalvular regurgitation, and conduction disturbances; careful data collection for continual outcome assessment and improvement; and the necessary expertize and procedural volume to maintain excellent outcomes and ensure optimal clinical care pathways.

Free full text

Supplemental Content

Full text links

Icon for Kare Publishing
Loading ...
Support Center